Sarcoidosis‐like reaction in metastatic triple negative breast cancer treated by anti‐PD‐L1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sarcoidosis‐like reaction in metastatic triple negative breast cancer treated by anti‐PD‐L1

Published:2019-06-04 Issue:5 Volume:25 Page:971-973
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Lafon Mathilde¹²,Blaye Celine¹²,Kind Michele³,Bechade Dominique¹,Chassaigne Florence⁴,Italiano Antoine¹²,Grellety Thomas¹²^ORCID

Affiliation:

1. Department of Medical Oncology Institut Bergonié, Comprehensive Cancer Centre Bordeaux Bordeaux France

2. University of Bordeaux Bordeaux France

3. Department of Radiology Institut Bergonié, Comprehensive Cancer Centre Bordeaux Bordeaux France

4. Department of Pathology Institut Bergonié, Comprehensive Cancer Centre Bordeaux Bordeaux France

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13386

Reference9 articles.

1. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

2. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma

3. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

4. Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission

5. Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping;Pathology - Research and Practice;2024-10

2. Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review;Frontiers in Oncology;2022-03-10

3. Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer;Case Reports in Oncological Medicine;2022-01-27

4. Microgravity: New aspect for breast cancer treatment, a review;Acta Astronautica;2022-01

5. Sarcoidosis Induced by Atezolizumab Presenting With Xanthelasma Infiltration;The American Journal of Dermatopathology;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3